1. Home
  2. SRCE vs NVAX Comparison

SRCE vs NVAX Comparison

Compare SRCE & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 1st Source Corporation

SRCE

1st Source Corporation

HOLD

Current Price

$73.60

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.66

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRCE
NVAX
Founded
1863
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
SRCE
NVAX
Price
$73.60
$8.66
Analyst Decision
Hold
Hold
Analyst Count
4
9
Target Price
$73.25
$11.33
AVG Volume (30 Days)
134.5K
3.4M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.15%
N/A
EPS Growth
19.59
309.76
EPS
6.41
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$10.29
N/A
Revenue Next Year
$3.16
N/A
P/E Ratio
$11.58
$3.25
Revenue Growth
N/A
64.69
52 Week Low
$53.63
$5.80
52 Week High
$75.16
$11.85

Technical Indicators

Market Signals
Indicator
SRCE
NVAX
Relative Strength Index (RSI) 68.71 48.12
Support Level $65.26 $8.09
Resistance Level N/A $9.05
Average True Range (ATR) 1.42 0.41
MACD 0.44 0.02
Stochastic Oscillator 82.40 62.61

Price Performance

Historical Comparison
SRCE
NVAX

About SRCE 1st Source Corporation

1st Source Corp provides specialized financing services for construction equipment, aircraft, and vehicle types through its Specialty Finance activities. The company offers commercial, small business, agricultural, and real estate loans, along with commercial leasing, treasury management, and payment services, including Fedwires, ACH, and merchant services. It also provides Renewable Energy Financing for commercial solar projects, a full range of consumer banking products, Trust and Wealth Advisory Services, and insurance products. The company operates in the commercial banking segment, which provides commercial and consumer banking services, trust and wealth advisory services, and insurance to individual and business clients across its markets.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: